Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000475710 | SCV000544855 | pathogenic | Marfan syndrome | 2016-10-01 | criteria provided, single submitter | clinical testing | This sequence change deletes 1 nucleotide from exon 10 of the FBN1 mRNA (c.1134delC), causing a frameshift at codon 379. This creates a premature translational stop signal (p.Ile379Serfs*16) and is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, loss-of-function variants in FBN1 are known to be pathogenic (PMID: 17657824, 19293843). For these reasons, this variant has been classified as Pathogenic. |
Ambry Genetics | RCV002313163 | SCV000738838 | pathogenic | Familial thoracic aortic aneurysm and aortic dissection | 2016-09-09 | criteria provided, single submitter | clinical testing | The c.1134delC pathogenic mutation, located in coding exon 9 of the FBN1 gene, results from a deletion of one nucleotide at position 1134, causing a translational frameshift with a predicted alternate stop codon (p.I379Sfs*16). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Labcorp Genetics |
RCV001380008 | SCV001577931 | pathogenic | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2016-10-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. While this particular variant has not been reported in the literature, loss-of-function variants in FBN1 are known to be pathogenic (PMID: 17657824, 19293843). This sequence change deletes 1 nucleotide from exon 10 of the FBN1 mRNA (c.1134delC), causing a frameshift at codon 379. This creates a premature translational stop signal (p.Ile379Serfs*16) and is expected to result in an absent or disrupted protein product. |